GREENBROOK TMS INC (GBNH) Stock Fundamental Analysis

NASDAQ:GBNH • CA3937043097

0.121 USD
-0.08 (-40.69%)
At close: Feb 23, 2024
0.1153 USD
-0.01 (-4.71%)
After Hours: 2/23/2024, 8:00:01 PM
Fundamental Rating

2

GBNH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of GBNH have multiple concerns. GBNH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • GBNH had negative earnings in the past year.
  • GBNH had a negative operating cash flow in the past year.
GBNH Yearly Net Income VS EBIT VS OCF VS FCFGBNH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -20M -40M -60M

1.2 Ratios

  • GBNH's Return On Assets of -78.11% is on the low side compared to the rest of the industry. GBNH is outperformed by 88.98% of its industry peers.
Industry RankSector Rank
ROA -78.11%
ROE N/A
ROIC N/A
ROA(3y)-46.27%
ROA(5y)-38.54%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GBNH Yearly ROA, ROE, ROICGBNH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 500 -500

1.3 Margins

  • GBNH's Gross Margin of 44.95% is fine compared to the rest of the industry. GBNH outperforms 75.42% of its industry peers.
  • GBNH's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for GBNH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y7.57%
GBNH Yearly Profit, Operating, Gross MarginsGBNH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 20 -20 40 -40 -60 -80

0

2. Health

2.1 Basic Checks

  • GBNH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, GBNH has more shares outstanding
  • GBNH has a worse debt/assets ratio than last year.
GBNH Yearly Shares OutstandingGBNH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M
GBNH Yearly Total Debt VS Total AssetsGBNH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

  • GBNH has an Altman-Z score of -3.13. This is a bad value and indicates that GBNH is not financially healthy and even has some risk of bankruptcy.
  • GBNH has a Altman-Z score of -3.13. This is amonst the worse of the industry: GBNH underperforms 82.20% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.13
ROIC/WACCN/A
WACC8.23%
GBNH Yearly LT Debt VS Equity VS FCFGBNH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M 60M 80M

2.3 Liquidity

  • GBNH has a Current Ratio of 0.52. This is a bad value and indicates that GBNH is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.52, GBNH is not doing good in the industry: 91.53% of the companies in the same industry are doing better.
  • GBNH has a Quick Ratio of 0.52. This is a bad value and indicates that GBNH is not financially healthy enough and could expect problems in meeting its short term obligations.
  • GBNH has a Quick ratio of 0.52. This is amonst the worse of the industry: GBNH underperforms 86.44% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52
GBNH Yearly Current Assets VS Current LiabilitesGBNH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

6

3. Growth

3.1 Past

  • GBNH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -49.69%.
  • The Revenue has grown by 47.06% in the past year. This is a very strong growth!
  • GBNH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 38.05% yearly.
EPS 1Y (TTM)-49.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.83%
Revenue 1Y (TTM)47.06%
Revenue growth 3Y24.64%
Revenue growth 5Y38.05%
Sales Q2Q%29.13%

3.2 Future

  • GBNH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.18% yearly.
  • GBNH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.01% yearly.
EPS Next Y58.2%
EPS Next 2Y35.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.64%
Revenue Next 2Y13.01%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
GBNH Yearly Revenue VS EstimatesGBNH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
GBNH Yearly EPS VS EstimatesGBNH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 -0.5 -1 -1.5 -2 -2.5

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GBNH. In the last year negative earnings were reported.
  • Also next year GBNH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GBNH Price Earnings VS Forward Price EarningsGBNH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GBNH Per share dataGBNH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as GBNH's earnings are expected to grow with 35.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.18%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • GBNH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GREENBROOK TMS INC

NASDAQ:GBNH (2/23/2024, 8:00:01 PM)

After market: 0.1153 -0.01 (-4.71%)

0.121

-0.08 (-40.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-08
Earnings (Next)04-15
Inst Owners2.68%
Inst Owner Change0%
Ins Owners17.86%
Ins Owner Change0%
Market Cap5.18M
Revenue(TTM)80.09M
Net Income(TTM)-68.03M
Analysts80
Price Target0.66 (445.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.87%
Min EPS beat(2)-25.16%
Max EPS beat(2)19.42%
EPS beat(4)1
Avg EPS beat(4)-92.49%
Min EPS beat(4)-241.74%
Max EPS beat(4)19.42%
EPS beat(8)4
Avg EPS beat(8)-44.04%
EPS beat(12)5
Avg EPS beat(12)-34.69%
EPS beat(16)5
Avg EPS beat(16)-37.93%
Revenue beat(2)1
Avg Revenue beat(2)-1.42%
Min Revenue beat(2)-5.97%
Max Revenue beat(2)3.14%
Revenue beat(4)1
Avg Revenue beat(4)-3.23%
Min Revenue beat(4)-6.06%
Max Revenue beat(4)3.14%
Revenue beat(8)4
Avg Revenue beat(8)-0.36%
Revenue beat(12)4
Avg Revenue beat(12)-2.38%
Revenue beat(16)7
Avg Revenue beat(16)-1.44%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-17.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.41
EYN/A
EPS(NY)-0.46
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS1.87
BVpS-1.01
TBVpS-1.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -78.11%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.95%
FCFM N/A
ROA(3y)-46.27%
ROA(5y)-38.54%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y7.57%
F-Score4
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.35%
Cap/Sales 0.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z -3.13
F-Score4
WACC8.23%
ROIC/WACCN/A
Cap/Depr(3y)0.26%
Cap/Depr(5y)206.71%
Cap/Sales(3y)0.03%
Cap/Sales(5y)1.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.83%
EPS Next Y58.2%
EPS Next 2Y35.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)47.06%
Revenue growth 3Y24.64%
Revenue growth 5Y38.05%
Sales Q2Q%29.13%
Revenue Next Year6.64%
Revenue Next 2Y13.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-31.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-818.75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.38%
OCF growth 3YN/A
OCF growth 5YN/A

GREENBROOK TMS INC / GBNH FAQ

What is the ChartMill fundamental rating of GREENBROOK TMS INC (GBNH) stock?

ChartMill assigns a fundamental rating of 2 / 10 to GBNH.


Can you provide the valuation status for GREENBROOK TMS INC?

ChartMill assigns a valuation rating of 1 / 10 to GREENBROOK TMS INC (GBNH). This can be considered as Overvalued.


What is the profitability of GBNH stock?

GREENBROOK TMS INC (GBNH) has a profitability rating of 1 / 10.